Related Experiment Video

Updated: May 24, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
16:40

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation

Published on: February 28, 2012

Implantable cardioverter defibrillators: risks accompany the life-saving benefits

Brett D Atwater1, James P Daubert

  • 1Electrophysiology Section, Cardiology Division, Department of Medicine, Duke Clinical Research Institute, Duke University Medical Centre, Durham, NC 27710, USA.

Heart (British Cardiac Society)
|March 17, 2012
PubMed

Insights

Implantable cardioverter defibrillators (ICDs) save lives from sudden cardiac arrest but have risks. This review balances ICD benefits against their weaknesses and disadvantages.

Area of Science:

  • Cardiology
  • Medical Devices
  • Public Health

Background:

  • Sudden cardiac arrest (SCA) is a leading cause of death in developed nations, with hundreds of thousands of cases annually in the USA.
  • Antiarrhythmic drugs have proven ineffective in preventing sudden cardiac death.
  • The implantable cardioverter defibrillator (ICD) is a validated therapeutic advancement in cardiovascular medicine.

Purpose of the Study:

  • To summarize the weaknesses, disadvantages, and risks associated with ICD therapy.
  • To provide a balanced perspective on ICDs, considering their proven life-saving benefits.

Main Methods:

  • This is a commentary, not a primary research study.
  • It synthesizes existing knowledge and clinical experience regarding ICD therapy.
  • The review focuses on a balanced assessment of risks versus benefits.

Main Results:

  • ICD use has increased significantly but varies geographically and by other measures.
  • Potential shortcomings and risks of ICD therapy are gaining attention.
  • The commentary aims to present a comprehensive overview of these aspects.

Conclusions:

  • ICDs offer significant life-saving benefits for patients at risk of sudden cardiac death.
  • A thorough understanding of ICD weaknesses, disadvantages, and risks is crucial.
  • Balanced consideration of both benefits and risks is essential for optimal patient care and therapy implementation.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.